MedPath

HEC68498 Sodium

Generic Name
HEC68498 Sodium

Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors

Phase 1
Completed
Conditions
Advanced Refractory Solid Tumors
Interventions
First Posted Date
2020-03-27
Last Posted Date
2022-08-12
Lead Sponsor
Sunshine Lake Pharma Co., Ltd.
Target Recruit Count
12
Registration Number
NCT04324372
Locations
🇨🇳

The Fifth Medical Center of PLA Ceneral Hospital, Beijing, China/BEIJING, China

The Safety, Tolerability and Pharmacokinetic Study of HEC68498 in Healthy Male and Female Subjects

Phase 1
Completed
Conditions
Idiopathic Pulmonary Fibrosis
Interventions
Drug: Placebo
First Posted Date
2018-04-19
Last Posted Date
2021-05-07
Lead Sponsor
Sunshine Lake Pharma Co., Ltd.
Target Recruit Count
55
Registration Number
NCT03502902
Locations
🇺🇸

Covance Clinical Research Unit, Inc., Daytona Beach, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath